Updated:
CiToxLAB Group
CiToxLAB Group is a contract research organization based in Roubaix, France, specializing in non-clinical safety testing for pharmaceuticals and chemicals.
CiToxLAB Group
CiToxLAB Group is a contract research organization headquartered in Roubaix, France, specializing in regulatory non-clinical safety testing. The firm's core business involves toxicology, pathology, and bioanalysis studies that support drug and chemical development programs for global pharmaceutical and industrial clients. Public records indicate the CRO operates facilities in both France and Canada, though exact founding year and ownership details remain undisclosed. The organization's service lines include general toxicology, reproductive toxicology, genetic toxicology, and carcinogenicity studies, along with analytical chemistry and pathology support. CiToxLAB positions its laboratories to meet OECD, FDA, and EMA standards, serving clients across Europe and North America. No named portfolio companies or specific co-investment deals have been publicly associated with the entity as of available sources. CiToxLAB's team size, revenue, and total deployment are not publicly available. The firm maintains a website at citoxlab.com that outlines its testing capabilities and facility locations. No recent operational events from the past 24 months have been identified through public sources, and no philanthropic vehicles or adjacent investment funds are disclosed. A key structural differentiator for CiToxLAB is its position as a specialized CRO rather than a traditional investment manager. This operating-company model means the entity generates returns through service revenue from regulated safety testing, not through capital allocation or fund structures. Governance and succession details are not publicly available, and the firm's ownership and ultimate beneficiaries remain opaque.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
France
City
Roubaix
Corporate office
Roubaix, France
Frequently asked questions
What services does CiToxLAB Group provide?
CiToxLAB Group offers non-clinical safety testing services including toxicology, pathology, and bioanalysis studies for pharmaceutical, chemical, and agrochemical industries. The firm's laboratories are configured to comply with OECD, FDA, and EMA regulatory standards. Services span general toxicology, reproductive toxicology, genetic toxicology, and carcinogenicity testing, as disclosed on the firm's website.
Where are CiToxLAB Group's facilities located?
The firm is headquartered in Roubaix, France, and public records indicate additional facilities in France and Canada. The specific addresses and number of laboratory sites are not disclosed in detail on the company's website.
Who owns CiToxLAB Group?
Ownership details for CiToxLAB Group are not publicly disclosed. The entity's financial structure, ultimate beneficiaries, and any relationship to family offices or investment groups remain opaque in public records.
Is CiToxLAB Group a family office or an operating company?
CiToxLAB Group operates as a contract research organization (CRO), generating revenue through laboratory testing services rather than managing investment capital. It is not structured as a family office or asset manager, though ownership may involve private investment groups not publicly identified.
Does CiToxLAB Group publish financial data?
CiToxLAB Group does not publicly disclose financial metrics such as revenue, assets under management, or deployment figures. The firm's website provides no financial statements or investor relations materials, and no such data appears in public databases.
What regulatory standards does CiToxLAB Group comply with?
The firm states its laboratories operate in compliance with OECD Good Laboratory Practice, FDA, and EMA guidelines. This regulatory posture supports the firm's service offerings for pharmaceutical and chemical clients seeking preclinical data for global submissions.
How does CiToxLAB Group differ from a traditional toxicology CRO?
CiToxLAB Group is primarily known for non-clinical safety testing, with a focus on general and reproductive toxicology. Its naming suggests a broader group structure, but operational details separate from typical CROs—such as ownership by a family office or private equity—are not confirmed by any public source.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: